This medicine is effective in treating overactive bladder (OAB) symptoms It reverses the conditions of frequency of passing urine, urgency, and incontinence by relaxing the muscles of the urinary bladder
In individuals with liver damage, use with caution; dosage modification may be required. Speak with a medical professional.
Moderation is advised; no specific interactions have been observed.
Before using while pregnant, speak with a healthcare professional.
There are no particular cautions mentioned, but steer clear of driving or using heavy machinery if you feel dizzy or have other side effects.
Patients with Kidney impairment should use this medication with caution; a dosage change may be required. Speak with a medical professional.
Mirabegron increases bladder capacity by relaxing the detrusor muscles present in the bladder; which provides relief to overactive bladder (OAB) patients from urinary frequency, urinary urgency and incontinence. Solifenacin reduces involuntary contractions of the detrusor muscles by blocking muscarinic receptors in the bladder; which provides relief to overactive bladder (OAB) patients from urinary frequency, urinary urgency and incontinence.
An abrupt, overwhelming urge to urinate is the hallmark of overactive bladder, which frequently results in urine loss that is not voluntary (urge incontinence). Another symptom of it could be nocturia, or the need to urinate often at night.
Master in Pharmacy
Content Updated on
Friday, 5 July, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA